PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy

EJNMMI Research

Table 4 Multivariate analysis for the association of ⁶⁸Ga-PSMA-11 PET findings with surgical margin status

	No. of patients	Odds ratio	95% CI	p value*
miTNM classification, no., n = 186
miT status
2	125	Reference
≥ 3a	61	2.065	0.802–5.315	0.133
miN status
No LN metastasis	168	Reference
With LN metastasis	18	5.428	1.708–17.249	0.004
SUV_max of prostatic lesions	183	1.015	0.988–1.044	0.282
TL of prostatic lesions	183	1.004	0.998–1.011	0.166

CI confidence interval, LN lymph node, PET positron emission tomography, PSMA prostate-specific membrane antigen, SUV standardized uptake value, TL total lesion, TV tumor volume
*Significant associations are given in bold